Researchers have identified genetic markers that could led to more accurate type 2 diabetes diagnoses in people of African ancestry, a population often underrepresented in genetic studies. The findings,published this week in Nature Genetics,highlight how current diagnostic criteria-largely based on studies of European populations-may miss cases or lead to misdiagnosis in african communities. This study, conducted in Uganda, underscores the growing need for diverse genomic research to address health disparities and improve healthcare equity globally, as diabetes rates continue to rise across the continent [1].
A new study conducted in Uganda has identified biological markers that could significantly improve the accuracy of type 2 diabetes diagnoses in people of African ancestry. The research highlights the importance of tailored medical approaches, recognizing that diagnostic tools developed primarily for European populations may not be as effective for individuals with different genetic backgrounds.
Currently, standard diagnostic methods for type 2 diabetes, such as hemoglobin testing to measure long-term blood sugar levels, are largely based on studies of European individuals. Researchers suggest these existing methods may be less precise when applied to African populations due to inherent genetic and biological differences.
The study, which involved 163 individuals with type 2 diabetes or prediabetes and 362 healthy Ugandan volunteers, revealed 58 previously unidentified genetic variations specific to people of African descent. Published in the journal Nature Genetics on Thursday, December 7, 2023, the findings indicate that 18 of these variations are linked to the development of type 2 diabetes, and some may be treatable with existing medications.
“By focusing on African populations, we are uncovering biological insights that have been missed in global diabetes research,” said Ubeyme Suri-komon of the University of Exeter, who led the study. “This demonstrates that a ‘one-size-fits-all’ approach to diagnosis and treatment is insufficient. We need solutions that reflect the diversity of human biology.”
The identification of these genetic markers could lead to more accurate and effective screening and treatment strategies for type 2 diabetes within African communities, a disease that poses a growing public health challenge globally. The research underscores the need for greater diversity in genomic studies to ensure equitable healthcare for all populations.
